MedPath

Investigation on the effect of topical application of a verum formulation on wound healing in a double-blind placebo-controlled study.

Not Applicable
Recruiting
Conditions
Epidermal und DermaleWound Healing after laser ablation
Registration Number
DRKS00031896
Lead Sponsor
COTY LANCASTER
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
12
Inclusion Criteria

Who are older than 40 years old
- Who have no known skin diseases
- who have a skin type of I-III (Fitzpatrick)
- Who have been informed about the aims of the study and the nature of the investigations.
- who have given their informed consent to participate in writing.
- who have not received intensive sun exposure on the skin areas to be irradiated on the forearm within the last 14 days before the irradiation date.

Exclusion Criteria

- Minors
- nursing mothers and women with known pregnancy
- Known skin diseases
- Skin type >III (Fitzpatrick)
- past ablative or peeling treatments of the forearm
- intensive sun exposure on the skin areas to be measured on the forearm within the last 14 days before the irradiation date
- Persons who cannot make decisions on their own responsibility

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diameter of micro-wounds measured with the LSM are smaller with the verum cream.
Secondary Outcome Measures
NameTimeMethod
Wound treated with verum cream heals better assessed by the clinic dermatologist
© Copyright 2025. All Rights Reserved by MedPath